Since 1993, Seaflower Ventures has established a reputation within the venture capital and entrepreneurial communities as a respected hands-on and value-added early stage life sciences investor.

Seaflower serves as an active collaborative partner with scientific entrepreneurs at all stages of development from start-up to exit. Seaflower will also serve as co-founder for a new start-up with scientific entrepreneurs, often serving as the initial management team. We have served as Chairman for over half of our portfolio companies.

Since 1993, Seaflower has invested personal capital and three venture capital funds in over 25 promising early stage life science and medical technology companies. Three Seaflower portfolio companies have completed successful IPOs to date, each generating a 15 times or greater return our investment: GelTex Pharmaceuticals (Nasdaq:GELX); Alpha-Beta Technologies (Nasdaq:ABTI); and EPIX Pharmaceuticals (Nasdaq:EPIX).

Since 1996, Seaflower portfolio companies have attracted over $250 million in follow-on investments from 45 top U.S. and international life science focused venture capital funds. Coinvestors in Seaflower portfolio companies include:

• Advanced Technology Ventures
• Alta Prospect
• Applied Genomic Technology Capital (AGTC)
• Atlas Venture
• BancOne Capital
• BA Venture Partners
• BD Ventures (Becton Dickinson & Co.)
• Bedrock Capital Partners
• Bessemer Venture Partners
• BioAsia Investments
• Boston Millennia Partners
• Burrill & Co.
• Cambrex Corp.
• Catalyst Health & Technology Partners
• CDP Capital-Technology Ventures
• CW Group
• Credit Suisse First Boston (CSFB)
• DWS (Deutsche Bank)
• Dekada
• Delphi Ventures
• Economic Development Board (EDB) of Singapore
• EDF Ventures
• Fisher Scientific Corp.
• Fuqua Ventures
• Fonds de Solidarité des Travailleurs du Québec (FTQ)

• GeneChem
• General Atlantic Partners
• Genzyme Corp.
• HIG Ventures
• Javelin Ventures
• Johnson & Johnson Development Corp.
• Mason Wells Biomedical Fund
• MDS Capital Corp.
• Morgan Stanley Dean Witter Venture Partners
• MPM Asset Management
• Massachusetts Technology Development Corporation (MTDC)
• New York Life Ventures
• Nomura Securities
• North Coast Technology Investors
• Oxford Bioscience Partners
• Pacific Venture Groups
• Pequot Venture Partners
• Portage Venture Partners
• ProgressNow! invest AG
• Radius Ventures
• The Stephens Group
• Schroder Ventures Life Sciences
• SROne
• T2C2 / Bio
• Tullis-Dickerson & Co.
• United Overseas Bank (UOB) of Singapore
• Venture Investors Management